什么是 SEC Form 13F 申报?美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
CIK: 0001920938
申报总市值
US$27.0亿
US$27.0亿
73 檔
27.7%
Q4 2025 季度申报显示,Braidwell LP 披露的美股组合总市值为 US$27.0亿,涵盖 73 个不同之权益投资仓位。
在 Q4 2025,Braidwell LP 展现出较为审慎的避险与获利了结姿态。本季共减仓 32 个仓位并完全清仓 20 档持股,调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面,Braidwell LP 的前 5 大核心持股(包含 CAI, GH 1.25 02-15-31, EWTX 等)合计占整体申报市值的 27.7%,反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CAI | Caris Life Sciences Inc | 股票-其他 | 6.74% | +0.66% | +6.83% | |
| 2 | GH 1.25 02-15-31债券 | Guardant Health Inc | 债券 | 6.15% | -3.42% | EXIT | |
| 3 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 4.14% | +0.53% | — | |
| 4 | RGEN 1 12-15-28债券 | Repligen CORP | 债券 | 3.54% | -2.68% | — | |
| 5 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 3.41% | -0.77% | -14.63% | |
| 6 | GKOS | Glaukos CORP | 股票-医疗保健 | 3.33% | +0.32% | +18.18% | |
| 7 | NEO 0.25 01-15-28债券 | Neogenomics Inc | 债券 | 2.87% | -2.44% | — | |
| 8 | NUVL | Nuvalent Inc-a | 股票-其他 | 2.64% | -2.39% | EXIT | |
| 9 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 2.62% | -0.07% | -49.37% | |
| 10 | CGON | Cg Oncology Inc | 股票-其他 | 2.48% | -2.22% | EXIT | |
| 11 | IRTC 1.5 09-01-29债券 | Irhythm Holdings Inc | 债券 | 2.33% | — | -16.13% | |
| 12 | HNGE | Hinge Health Inc-a | 股票-其他 | 1.94% | +2.21% | +43.29% | |
| 13 | ALGN | Align Technology Inc | 股票-医疗保健 | 1.90% | — | -7.00% | |
| 14 | KOD | Kodiak Sciences Inc | 股票-其他 | 1.85% | +0.27% | — | |
| 15 | SLNOEUR | Soleno Therapeutics Inc | 股票-其他 | 1.76% | -1.07% | EXIT | |
| 16 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 1.75% | -2.63% | EXIT | |
| 17 | NEO | Neogenomics Inc | 股票-医疗保健 | 1.74% | +1.26% | +161.57% | |
| 18 | ACAD | Acadia Pharmaceuticals Inc | 股票-医疗保健 | 1.74% | -0.30% | -14.57% | |
| 19 | SYRE | Spyre Therapeutics Inc | 股票-其他 | 1.71% | +1.32% | -36.60% | |
| 20 | DNTH | Dianthus Therapeutics Inc | 股票-其他 | 1.68% | -0.38% | +52.56% | |
| 21 | IRWD 1.5 06-15-26债券 | Ironwood Pharmaceuticals | 债券 | 1.61% | — | -34.98% | |
| 22 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.61% | -0.83% | +214.03% | |
| 23 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 1.60% | -0.05% | -38.80% | |
| 24 | KRYS | Krystal Biotech Inc | 股票-医疗保健 | 1.59% | +0.20% | -61.16% | |
| 25 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 1.51% | -0.16% | -35.94% | |
| 26 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 1.50% | +0.14% | -29.15% | |
| 27 | BTSG | Brightspring Health Services | 股票-其他 | 1.43% | +0.10% | — | |
| 28 | CVS | Cvs Health CORP | 股票-医疗保健 | 1.43% | -0.70% | EXIT | |
| 29 | APGE | Apogee Therapeutics Inc | 股票-其他 | 1.39% | -1.34% | EXIT | |
| 30 | NRIX | Nurix Therapeutics Inc | 股票-其他 | 1.32% | +0.24% | — | |
| 31 | VERA | Vera Therapeutics Inc | 股票-其他 | 1.27% | +0.20% | +66.00% | |
| 32 | IRTC | Irhythm Holdings Inc | 股票-医疗保健 | 1.23% | +0.48% | -3.76% | |
| 33 | TMDX | Transmedics Group Inc | 股票-医疗保健 | 1.23% | +0.41% | -10.22% | |
| 34 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 1.14% | -0.94% | EXIT | |
| 35 | ILMN | Illumina Inc | 股票-医疗保健 | 1.13% | -0.94% | EXIT | |
| 36 | KYMR | Kymera Therapeutics Inc | 股票-其他 | 1.13% | +0.66% | +64.17% | |
| 37 | FULC | Fulcrum Therapeutics Inc | 股票-其他 | 1.11% | -0.80% | EXIT | |
| 38 | PEN | Penumbra Inc | 股票-医疗保健 | 1.10% | -1.15% | EXIT | |
| 39 | MBX | Mbx Biosciences Inc | 股票-其他 | 1.03% | -0.04% | — | |
| 40 | RAPT | Rapt Therapeutics Inc | 股票-其他 | 1.01% | — | — | |
| 41 | CDNA | Caredx Inc | 股票-其他 | 0.96% | +0.03% | -27.38% | |
| 42 | DYN | Dyne Therapeutics Inc | 股票-其他 | 0.92% | -0.26% | -45.86% | |
| 43 | ✓ | Engene Holdings Inc | 股票-其他 | 0.90% | -0.56% | EXIT | |
| 44 | LEGN | Legend Biotech Corp-adr | 股票-其他 | 0.90% | — | -28.91% | |
| 45 | MRVI | Maravai Lifesciences Hldgs-a | 股票-其他 | 0.87% | +1.04% | — | |
| 46 | DHR | Danaher CORP | 股票-医疗保健 | 0.87% | +0.18% | -61.78% | |
| 47 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 0.83% | -1.46% | -59.25% | |
| 48 | NTRA | Natera Inc | 股票-医疗保健 | 0.82% | -0.06% | — | |
| 49 | DRUG | Bright Minds Biosciences Inc | 股票-其他 | 0.81% | -0.05% | +6.81% | |
| 50 | 430 | Terns Pharmaceuticals Inc | 股票-其他 | 0.74% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | EWTX | Edgewise Therapeutics Inc | +1.6% | — | 不变 |
| 2 | GKOS | Glaukos CORP | +1.4% | +18.18% | 加仓 |
| 3 | NEO | Neogenomics Inc | +1.3% | +161.57% | 加仓 |
| 4 | CLDX | Celldex Therapeutics Inc | +1.2% | +214.03% | 加仓 |
| 5 | FULC | Fulcrum Therapeutics Inc | +1.1% | +1294.71% | 加仓 |
| 6 | VERA | Vera Therapeutics Inc | +0.9% | +66.00% | 加仓 |
| 7 | DNTH | Dianthus Therapeutics Inc | +0.7% | +52.56% | 加仓 |
| 8 | KYMR | Kymera Therapeutics Inc | +0.7% | +64.17% | 加仓 |
| 9 | HNGE | Hinge Health Inc-a | +0.6% | +43.29% | 加仓 |
| 10 | RGEN 1 12-15-28债券 | Repligen CORP | +0.5% | — | 不变 |
| 11 | CVS | Cvs Health CORP | +0.5% | +28.64% | 加仓 |
| 12 | ✓ | Engene Holdings Inc | +0.4% | +38.17% | 加仓 |
| 13 | SYRE | Spyre Therapeutics Inc | +0.4% | -36.60% | 减仓 |
| 14 | ALGN | Align Technology Inc | +0.4% | -7.00% | 减仓 |
| 15 | SRZN | Surrozen Inc | +0.3% | +235.71% | 加仓 |
| 16 | BMRN | Biomarin Pharmaceutical Inc | +0.3% | +13.92% | 加仓 |
| 17 | NEO 0.25 01-15-28债券 | Neogenomics Inc | +0.3% | — | 不变 |
| 18 | TECX | Tectonic Therapeutic Inc | +0.3% | +25.87% | 加仓 |
| 19 | DRUG | Bright Minds Biosciences Inc | +0.3% | +6.81% | 加仓 |
| 20 | ACAD | Acadia Pharmaceuticals Inc | +0.2% | -14.57% | 减仓 |
| 21 | ✓ | Zura Bio LTD | +0.2% | +28.61% | 加仓 |
| 22 | CAI | Caris Life Sciences Inc | +0.2% | +6.83% | 加仓 |
| 23 | MRVI | Maravai Lifesciences Hldgs-a | +0.2% | — | 不变 |
| 24 | IRTC | Irhythm Holdings Inc | +0.1% | -3.76% | 减仓 |
| 25 | TMDX | Transmedics Group Inc | +0.1% | -10.22% | 减仓 |
| 26 | NUVL | Nuvalent Inc-a | 0% | -18.91% | 减仓 |
| 27 | PEN | Penumbra Inc | 0% | -22.17% | 减仓 |
| 28 | CDNA | Caredx Inc | 0% | -27.38% | 减仓 |
| 29 | KIDS | Orthopediatrics CORP | 0% | -0.67% | 减仓 |
| 30 | LUNG | Pulmonx CORP | 0% | — | 不变 |
| 31 | HROW | Harrow Inc | 0% | -13.76% | 减仓 |
| 32 | DYN | Dyne Therapeutics Inc | -0.1% | -45.86% | 减仓 |
| 33 | TMO | Thermo Fisher Scientific Inc | -0.1% | -29.15% | 减仓 |
| 34 | ADPT | Adaptive Biotechnologies | -0.2% | -57.61% | 减仓 |
| 35 | IRTC 1.5 09-01-29债券 | Irhythm Holdings Inc | -0.2% | -16.13% | 减仓 |
| 36 | XNCR | Xencor Inc | -0.2% | -63.16% | 减仓 |
| 37 | ISRG | Intuitive Surgical Inc | -0.2% | -35.94% | 减仓 |
| 38 | NBIX | Neurocrine Biosciences Inc | -0.3% | -14.63% | 减仓 |
| 39 | APGE | Apogee Therapeutics Inc | -0.3% | -60.03% | 减仓 |
| 40 | KNSA | Kiniksa Pharmaceuticals International, plc | -0.3% | -51.21% | 减仓 |
| 41 | CSTL | Castle Biosciences Inc | -0.3% | -78.46% | 减仓 |
| 42 | INSP | Inspire Medical Systems Inc | -0.4% | -38.80% | 减仓 |
| 43 | RGEN | Repligen CORP | -0.4% | -58.20% | 减仓 |
| 44 | IRWD 1.5 06-15-26债券 | Ironwood Pharmaceuticals | -0.6% | -34.98% | 减仓 |
| 45 | ORKA | Oruka Therapeutics Inc | -0.7% | -93.87% | 减仓 |
| 46 | SLNOEUR | Soleno Therapeutics Inc | -0.8% | -7.34% | 减仓 |
| 47 | ARGX | Argenx Se - Adr | -0.8% | -59.25% | 减仓 |
| 48 | LEGN | Legend Biotech Corp-adr | -0.9% | -28.91% | 减仓 |
| 49 | DHR | Danaher CORP | -1% | -61.78% | 减仓 |
| 50 | KRYS | Krystal Biotech Inc | -1.1% | -61.16% | 减仓 |
根据 SEC 官方 Form 13F 申报备案,Braidwell LP 在 Q4 2025 季度的美股持仓总市值约为 US$27.0亿,共申报了 73 个公开持股仓位。
在 Q4 2025 季度,Braidwell LP 按市值排列的前三大核心持股分别为:CAI (6.7%)、GH 1.25 02-15-31 (6.2%)、EWTX (4.1%)。其中最大持股仓位 CAI 占据整体投资组合约 6.7% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析,提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
KOD
市值: US$5795.5万
本季最大获利了结 / 清仓标的
NVCR 0 11-01-25
前期市值: US$2.1亿
在 Q4 2025 季度中,Braidwell LP 共进行了 88 项持仓异动,包含新建仓 20 个仓位、加仓 16 个仓位、减仓 32 个仓位以及清仓 20 个仓位。 其中最大新建仓标的为 KOD。 本季清仓仓位包含 NVCR 0 11-01-25。
本页面所有持股数据均直接同步自美国证券交易委员会(SEC)EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照,提供 100% 精准对齐的历史时序数据集,并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报,掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异,以及最新 SEC 申报时程规范,洞察机构法人的激进投资动向。